466 related articles for article (PubMed ID: 33596496)
1. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2021 Apr; 221():108555. PubMed ID: 33596496
[TBL] [Abstract][Full Text] [Related]
2. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
[TBL] [Abstract][Full Text] [Related]
3. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
4. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
Samples H; Williams AR; Olfson M; Crystal S
J Subst Abuse Treat; 2018 Dec; 95():9-17. PubMed ID: 30352671
[TBL] [Abstract][Full Text] [Related]
6. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
7. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
[TBL] [Abstract][Full Text] [Related]
8. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.
Tardelli V; Xu KY; Bisaga A; Levin FR; Fidalgo TM; Grucza RA
BMJ Ment Health; 2023 Jul; 26(1):. PubMed ID: 37500184
[TBL] [Abstract][Full Text] [Related]
9. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
10. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
Swartz JA; Franceschini D; Scamperle K
AIMS Public Health; 2023; 10(3):658-677. PubMed ID: 37842281
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of co-occurring substance use in individuals with opioid use disorder.
Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder.
Ellis MS; Xu KY; Tardelli VS; Fidalgo TM; Buttram ME; Grucza RA
JAMA Psychiatry; 2023 Dec; 80(12):1269-1276. PubMed ID: 37672238
[TBL] [Abstract][Full Text] [Related]
14. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
15. Opioid medication discontinuation and risk of adverse opioid-related health care events.
Mark TL; Parish W
J Subst Abuse Treat; 2019 Aug; 103():58-63. PubMed ID: 31079950
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005-2016.
Charron E; Rennert L; Mayo RM; Eichelberger KY; Dickes L; Truong KD
Drug Alcohol Depend; 2021 Mar; 220():108533. PubMed ID: 33513446
[TBL] [Abstract][Full Text] [Related]
17. An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program.
Cochran G; Gordon AJ; Lo-Ciganic WH; Gellad WF; Frazier W; Lobo C; Chang CH; Zheng P; Donohue JM
Med Care; 2017 Mar; 55(3):291-298. PubMed ID: 27984346
[TBL] [Abstract][Full Text] [Related]
18. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
19. Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study.
Macmadu A; Paull K; Youssef R; Batthala S; Wilson KH; Samuels EA; Yedinak JL; Marshall BDL
Drug Alcohol Depend; 2021 Feb; 219():108435. PubMed ID: 33310383
[TBL] [Abstract][Full Text] [Related]
20. Opioid Use Disorder among Hospitalized Adults in North Carolina: Analysis from the 2000-2020 NC State Inpatient Database.
Alemu BT; Beydoun HA; Olayinka O; Harmer B; Brown AR
South Med J; 2024 May; 117(5):226-234. PubMed ID: 38701842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
